We are live on ! Find out more
Commonwealth Equity Services

Commonwealth Equity Services Portfolio holdings

AUM $79.5B
1-Year Est. Return 27.1%
This Fund
S&P 500
This Quarter Est. Return
+8.08%
1 Year Est. Return
+27.1%
3 Year Est. Return
+78.53%
5 Year Est. Return
+87.9%
10 Year Est. Return
+281.21%
AUM
$41.6B
AUM Growth
+$2.78B
Cap. Flow
+$1.7B
Cap. Flow %
4.09%
Top 10 Hldgs %
16.13%
Holding
3,882
New
219
Increased
1,735
Reduced
1,600
Closed
179

Sector Composition

Rank Sector Weight
1 Technology 9.27%
2 Financials 5.67%
3 Healthcare 5.44%
4 Consumer Discretionary 3.73%
5 Industrials 3.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SQFT icon
3501
Presidio Property Trust
SQFT
$2.84M
$57K ﹤0.01%
6,011
+4,387
+270% +$49.4K
SHCR
3502
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$57K ﹤0.01%
35,785
+6,612
+23% +$12.2K
CIK
3503
Credit Suisse Asset Management Income Fund
CIK
$134M
$56K ﹤0.01%
22,432
+144
+0.6% +$375
WIT icon
3504
Wipro
WIT
$19.3B
$56K ﹤0.01%
24,268
-70
-0.3% -$167
AXTI icon
3505
AXT Inc
AXTI
$3.07B
$55K ﹤0.01%
12,780
BWAY
3506
Brainsway
BWAY
$612M
$55K ﹤0.01%
+45,200
New +$62.2K
GPRO icon
3507
GoPro
GPRO
$124M
$52K ﹤0.01%
10,455
-1,300
-11% -$6.82K
OTLY
3508
Oatly Group
OTLY
$460M
$52K ﹤0.01%
1,522
-63
-4% -$2.4K
PL icon
3509
Planet Labs
PL
$7.21B
$52K ﹤0.01%
12,085
-1,585
-12% -$8.21K
OKUR
3510
OnKure Therapeutics
OKUR
$162M
$52K ﹤0.01%
2,235
ASTS icon
3511
AST SpaceMobile
ASTS
$17.5B
$51K ﹤0.01%
10,776
-3,214
-23% -$19.4K
HRTX icon
3512
Heron Therapeutics
HRTX
$94.1M
$51K ﹤0.01%
20,612
-525
-2% -$1.69K
GSAT icon
3513
Globalstar
GSAT
$10.3B
$50K ﹤0.01%
2,531
-1,141
-31% -$30K
VMEO
3514
DELISTED
Vimeo
VMEO
$50K ﹤0.01%
14,667
+4,313
+42% +$16.7K
BODI icon
3515
The Beachbody Company
BODI
$72.3M
$50K ﹤0.01%
1,919
+568
+42% +$24.7K
JMIA
3516
Jumia Technologies
JMIA
$739M
$48K ﹤0.01%
15,196
+2,105
+16% +$9.49K
USAU icon
3517
US Gold Corp
USAU
$223M
$48K ﹤0.01%
10,000
NMTR
3518
DELISTED
9 Meters Biopharma
NMTR
$48K ﹤0.01%
38,141
+18,411
+93% +$42K
ADMA icon
3519
ADMA Biologics
ADMA
$2.01B
$46K ﹤0.01%
11,902
+1,792
+18% +$5.53K
BARK icon
3520
BARK
BARK
$77.6M
$46K ﹤0.01%
1,562
-97
-6% -$3.23K
LXRX icon
3521
Lexicon Pharmaceuticals
LXRX
$1.04B
$46K ﹤0.01%
24,469
-107
-0.4% -$228
CELU icon
3522
Celularity
CELU
$19.7M
$45K ﹤0.01%
3,522
-1,379
-28% -$25.4K
INSG icon
3523
Inseego
INSG
$111M
$45K ﹤0.01%
5,442
-766
-12% -$11.5K
PBYI icon
3524
Puma Biotechnology
PBYI
$402M
$45K ﹤0.01%
+10,859
New +$37.5K
UBX
3525
DELISTED
Unity Biotechnology
UBX
$43K ﹤0.01%
16,013
+11,712
+272% +$34K

Similar funds

Commonwealth Equity Services's Q4 2022 Portfolio in Review

As of Q4 2022, Commonwealth Equity Services held 3,882 positions worth $41.6B, up 7.2% from $38.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Commonwealth Equity Services deployed $1.7B of net new capital in Q4 2022, opening 219 new positions and adding to 1,735 existing holdings. Its largest new stake was FS Credit Opportunities Corp: 5,433,129 shares worth $25.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 13% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $30.9M trimmed.

  • Commonwealth Equity Services's largest Q4 2022 buy was FS Credit Opportunities Corp: 5,433,129 shares worth $25.6M.
  • Commonwealth Equity Services added most to iShares Core US Aggregate Bond ETF in Q4 2022, an estimated $50.6M increase.
  • Commonwealth Equity Services's biggest Q4 2022 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $30.9M.
  • Commonwealth Equity Services fully exited Invesco BulletShares 2022 Corporate Bond ETF in Q4 2022, selling an estimated $15.2M.
  • Commonwealth Equity Services's ten largest holdings make up 16% of its $41.6B portfolio in Q4 2022.
  • Commonwealth Equity Services opened 219 new positions and closed 179 in Q4 2022.
  • Commonwealth Equity Services's portfolio value rose 7.2% quarter-over-quarter to $41.6B.

Based on Commonwealth Equity Services's 13F filing for Q4 2022, filed 7 Feb 2023.